Altered peripheral BDNF mRNA expression and BDNF protein concentrations in blood of children and adolescents with autism spectrum disorder (Q50343426)

5 March 2018

title

Altered peripheral BDNF mRNA expression and BDNF protein concentrations in blood of children and adolescents with autism spectrum disorder (English)

1 reference

5 March 2018

main subject

autism spectrum disorder

0 references

0 references

1 reference

5

1 reference

5 March 2018

Susanne Walitza

6

1 reference

5 March 2018

Martin Schecklmann

3

Martin Schecklmann

1 reference

5 March 2018

Manfred Gerlach

16

Manfred Gerlach

1 reference

5 March 2018

Marcel Romanos

15

Marcel Romanos

1 reference

5 March 2018

Regina Taurines

1

Regina Taurines

1 reference

5 March 2018

author name string

Monica Segura

2

1 reference

5 March 2018

Laura Albantakis

4

1 reference

5 March 2018

Thomas Jans

7

1 reference

5 March 2018

Benjamin Lyttwin

8

1 reference

5 March 2018

Michael Haberhausen

9

1 reference

5 March 2018

Frank M Theisen

10

1 reference

5 March 2018

Berthold Martin

11

1 reference

5 March 2018

Wolfgang Briegel

12

1 reference

5 March 2018

Johannes Thome

13

1 reference

5 March 2018

Christina Schwenck

14

1 reference

5 March 2018

publication date

6 February 2014

1 reference

5 March 2018

Journal of Neural Transmission

published in

1 reference

5 March 2018

volume

121

1 reference

5 March 2018

issue

9

1 reference

5 March 2018

page(s)

1117-1128

1 reference

5 March 2018

Behavioral Problems and Competencies Reported by Parents of Normal and Disturbed Children Aged Four Through Sixteen

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS00702-014-1162-X

Relationship between Sonic hedgehog protein, brain-derived neurotrophic factor and oxidative stress in autism spectrum disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-014-1162-X

HuD promotes BDNF expression in brain neurons via selective stabilization of the BDNF long 3'UTR mRNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-014-1162-X

Psychiatric vulnerability: suggestions from animal models and role of neurotrophins

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-014-1162-X

The neurotrophins NT-4/5 and BDNF augment serotonin, dopamine, and GABAergic systems during behaviorally effective infusions to the substantia nigra.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-014-1162-X

21 January 2018

Neuroanatomy of autism

1 reference

https://api.crossref.org/works/10.1007%2FS00702-014-1162-X

Working memory deficits in high-functioning adolescents with autism spectrum disorders: neuropsychological and neuroimaging correlates

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-014-1162-X

BDNF is essential to promote persistence of long-term memory storage

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-014-1162-X

Cellular sources of enhanced brain-derived neurotrophic factor production in a mouse model of allergic inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-014-1162-X

Characterizing cognition in ADHD: beyond executive dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-014-1162-X

Association study between BDNF gene polymorphisms and autism by three-dimensional gel-based microarray.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-014-1162-X

Brain-derived neurotrophic factor and autoantibodies to neural antigens in sera of children with autistic spectrum disorders, Landau-Kleffner syndrome, and epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-014-1162-X

Increased BDNF levels and NTRK2 gene association suggest a disruption of BDNF/TrkB signaling in autism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-014-1162-X

Brain-derived neurotrophic factor and autism: maternal and infant peripheral blood levels in the Early Markers for Autism (EMA) Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-014-1162-X

Antidepressants and neuroplasticity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-014-1162-X

Brain-derived neurotrophic factor: role in depression and suicide

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-014-1162-X

The BDNF val66met polymorphism affects activity-dependent secretion of BDNF and human memory and hippocampal function

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-014-1162-X

Detection of brain-derived neurotrophic factor (BDNF) in rat blood and brain preparations using ELISA: pitfalls and solutions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-014-1162-X

Autistic disorders - the state of the art and recent findings: epidemiology, aetiology, diagnostic criteria, and therapeutic interventions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-014-1162-X

Genetics of autistic disorders: review and clinical implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-014-1162-X

Effect of antipsychotic drugs on brain-derived neurotrophic factor expression under reduced N-methyl-D-aspartate receptor activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-014-1162-X

Association of COMT (Val158Met) and BDNF (Val66Met) gene polymorphisms with anxiety, ADHD and tics in children with autism spectrum disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-014-1162-X

A clinical and laboratory evaluation of methionine cycle-transsulfuration and androgen pathway markers in children with autistic disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-014-1162-X

Increased brain-derived neurotrophic factor expression in white blood cells of relapsing-remitting multiple sclerosis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-014-1162-X

Effects of 4-week treatment with lithium and olanzapine on levels of brain-derived neurotrophic factor, B-cell CLL/lymphoma 2 and phosphorylated cyclic adenosine monophosphate response element-binding protein in the sub-regions of the hippocampus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-014-1162-X

Reduced serum levels of brain-derived neurotrophic factor in adult male patients with autism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-014-1162-X

Executive dysfunction in autism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-014-1162-X

Modulatory effects of sex steroid hormones on brain-derived neurotrophic factor-tyrosine kinase B expression during adolescent development in C57Bl/6 mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-014-1162-X

Interaction between BDNF Val66Met and dopamine transporter gene variation influences anxiety-related traits.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-014-1162-X

BDNF-restricted knockout mice as an animal model for aggression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-014-1162-X

Plasma brain-derived neurotrophic factor concentrations in children and adolescents.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-014-1162-X

Postnatal developmental profile of brain-derived neurotrophic factor in rat brain and platelets

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-014-1162-X

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-014-1162-X

BDNF regulates eating behavior and locomotor activity in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-014-1162-X

Activated human T cells, B cells, and monocytes produce brain-derived neurotrophic factor in vitro and in inflammatory brain lesions: a neuroprotective role of inflammation?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-014-1162-X

Blood BDNF concentrations reflect brain-tissue BDNF levels across species

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-014-1162-X

Sleep in children with autism spectrum disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-014-1162-X

Sleep problems associated with ADHD: a review of current therapeutic options and recommendations for the future

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-014-1162-X

The impact of age, weight and gender on BDNF levels in human platelets and plasma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-014-1162-X

Autism diagnostic observation schedule: a standardized observation of communicative and social behavior

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-014-1162-X

Autism Diagnostic Interview-Revised: a revised version of a diagnostic interview for caregivers of individuals with possible pervasive developmental disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-014-1162-X

New insights into BDNF function in depression and anxiety

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-014-1162-X

Comorbid psychopathology with autism spectrum disorder in children: an overview

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-014-1162-X

Brain-derived neurotrophic factor expression is increased in the rat amygdala, piriform cortex and hypothalamus following repeated amphetamine administration

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-014-1162-X

Serum neurotrophin concentrations in autism and mental retardation: a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-014-1162-X

Genetic analyses of the brain-derived neurotrophic factor (BDNF) gene in autism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-014-1162-X

Comorbidity in autism spectrum disorders - I. Mental retardation and psychiatric comorbidity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-014-1162-X

Transport of brain-derived neurotrophic factor across the blood-brain barrier

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-014-1162-X

Brain-derived neurotrophic factor gene and protein expression in pediatric and adult depressed subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-014-1162-X

Role of neurotrophic factors in behavioral processes: implications for the treatment of psychiatric and neurodegenerative disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-014-1162-X

Differential effects of aripiprazole and haloperidol on BDNF-mediated signal changes in SH-SY5Y cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-014-1162-X

Toward a developmental neurobiology of autism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-014-1162-X

Neurotrophins as synaptic modulators

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-014-1162-X

Influence of brain-derived neurotrophic-factor and apolipoprotein E genetic variants on hippocampal volume and memory performance in healthy young adults.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-014-1162-X

Set shifting and working memory in adults with attention-deficit/hyperactivity disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-014-1162-X

Shared heritability of attention-deficit/hyperactivity disorder and autism spectrum disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-014-1162-X

Increased serum androstenedione in adults with autism spectrum conditions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-014-1162-X

Sex-specific serum biomarker patterns in adults with Asperger's syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-014-1162-X

Serum brain-derived neurotrophic factor, depression, and antidepressant medications: meta-analyses and implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-014-1162-X

Increased levels of plasma brain-derived neurotrophic factor (BDNF) in children with attention deficit-hyperactivity disorder (ADHD).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-014-1162-X

Alterations of serum levels of brain-derived neurotrophic factor (BDNF) in depressed patients with or without antidepressants

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-014-1162-X

BDNF increases monoaminergic activity in rat brain following intracerebroventricular or intraparenchymal administration.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-014-1162-X

Developmental comorbidity in attention-deficit/hyperactivity disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-014-1162-X

ADHD and autism: differential diagnosis or overlapping traits? A selective review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-014-1162-X

BDNF Val66Met is associated with introversion and interacts with 5-HTTLPR to influence neuroticism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-014-1162-X

Brain-derived neurotrophic factor and antidepressant action: another piece of evidence from pharmacogenetics

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-014-1162-X

Rare chromosomal deletions and duplications in attention-deficit hyperactivity disorder: a genome-wide analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-014-1162-X

Promoter specific alterations of brain-derived neurotrophic factor mRNA in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-014-1162-X

Role for brain-derived neurotrophic factor in learning and memory

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-014-1162-X

Neuropeptides and neurotrophins in neonatal blood of children with autism or mental retardation

21 January 2018

1 reference

12 December 2020

The functional neuroanatomy of autism.

1 reference

12 December 2020

Regulation of brain-derived neurotrophic factor expression in neurons

1 reference

12 December 2020

A prospective assessment of androgen levels in patients with autistic spectrum disorders: biochemical underpinnings and suggested therapies.

1 reference

12 December 2020

The neuropathology of autism: where do we stand?

1 reference

12 December 2020

Salivary testosterone levels and autism-spectrum quotient in adults

1 reference

12 December 2020

Serum brain-derived neurotrophic factor (BDNF) levels in attention deficit-hyperactivity disorder (ADHD).

1 reference

12 December 2020

Low Brain-Derived Neurotrophic Factor (BDNF) levels in serum of depressed patients probably results from lowered platelet BDNF release unrelated to platelet reactivity

1 reference

12 December 2020

1 reference

12 December 2020

The BDNF Val66Met polymorphism modulates sleep intensity: EEG frequency- and state-specificity.

1 reference

12 December 2020

Increased hippocampal BDNF immunoreactivity in subjects treated with antidepressant medication

1 reference

12 December 2020

Brain-derived neurotrophic factor is stored in human platelets and released by agonist stimulation.

1 reference

12 December 2020

Polyacrylamide gel-based microarray: a novel method applied to the association Study between the polymorphisms of BDNF gene and autism.

1 reference

12 December 2020

Decreased serum levels of brain-derived neurotrophic factor in adults with attention-deficit hyperactivity disorder.

1 reference

12 December 2020

10.1007/S00702-014-1162-X

Identifiers

DOI

1 reference

5 March 2018

1 reference

5 March 2018